Cargando…
A randomized controlled trial of botulinum toxin A for treating neuropathic pain in patients with spinal cord injury
BACKGROUND: To assess the effect of botulinum toxin A (BTA) for treating neuropathic pain in patients with spinal cord injury (SCI). METHODS: A total of 44 patients with SCI with neuropathic pain were randomly divided into the intervention group and the placebo group, each group 21 patients. The sub...
Autores principales: | Li, Gang, Lv, Chang-an, Tian, Li, Jin, Lian-jin, Sun, Ping, Zhao, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440146/ https://www.ncbi.nlm.nih.gov/pubmed/28514309 http://dx.doi.org/10.1097/MD.0000000000006919 |
Ejemplares similares
-
Burst spinal cord stimulation for central neuropathic pain: Two case reports
por: Yoon, Lim-joon, et al.
Publicado: (2021) -
Botulinum toxin type A for neuropathic pain in patients with spinal cord injury
por: Han, Zee‐A, et al.
Publicado: (2016) -
A randomized controlled trial of botulinum toxin A for treating
neuropathic pain in patients with spinal cord injury: Retraction
Publicado: (2017) -
Botulinum toxin in the treatment of trigeminal neuralgia: 6-Month follow-up
por: Türk Börü, Ülkü, et al.
Publicado: (2017) -
Cortical somatosensory processing after botulinum toxin therapy in post-stroke spasticity
por: Veverka, Tomáš, et al.
Publicado: (2021)